Advertisement
Advertisement
U.S. Markets close in 4 hrs 59 mins
Advertisement
Advertisement
Advertisement
Advertisement

Aethlon Medical, Inc. (AEMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.3711-0.0089 (-2.34%)
As of 10:36AM EDT. Market open.
Advertisement

Aethlon Medical, Inc.

11555 Sorrento Valley Road
Suite 203
San Diego, CA 92121
United States
619 941 0360
https://www.aethlonmedical.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees14

Key Executives

NameTitlePayExercisedYear Born
Dr. Charles J. Fisher Jr., M.D.CEO, Director & Member of Extracorporeal Therapy Advisory Board866.25kN/A1947
Mr. Steven P. Larosa M.D.Chief Medical Officer & Acting Chief Scientific Officer655.34kN/A1967
Mr. Guy F. Cipriani BS (Eng.), MBASr. VP, Chief Bus. Officer & Director635.61kN/A1970
Mr. James B. Frakes M.B.A.CFO, Sr. VP of Fin. & Sec.N/AN/A1957
Mr. Sunil SawhneyHead of Clinical StudiesN/AN/AN/A
Dr. Richard H. Tullis Ph.D.ConsultantN/AN/A1945
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

Corporate Governance

Aethlon Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement